Glaucoma Laser Assessment of Stability and Sustainability

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

August 31, 2027

Conditions
Glaucoma
Interventions
DEVICE

Dual-Treatment Direct Selective Laser Trabeculoplasty (DSLT)

This is the first clinical study to evaluate repeat bilateral Direct Selective Laser Trabeculoplasty (DSLT) in treatment-naïve patients, using a paired-eye design. Unlike prior SLT studies, which focused on monocular treatment or repeat treatment following IOP rebound, this study randomizes one eye to receive a second DSLT treatment three months after the first, while the fellow eye receives only a single treatment. This allows for a direct intra-subject comparison of efficacy and durability. Existing studies, including GLAUrious and LiGHT, suggest the potential benefits of repeat laser, but no data currently exist for early, scheduled repeat treatment with DSLT. This trial uniquely investigates whether proactively repeating the procedure in a controlled eye extends IOP reduction and delays or reduces the need for topical medications.

Trial Locations (1)

55433

RECRUITING

Twin Cities Eye Consultants, Coon Rapids

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Twin Cities Eye Consultants

OTHER

NCT06963684 - Glaucoma Laser Assessment of Stability and Sustainability | Biotech Hunter | Biotech Hunter